Redeye: Stille Q4 2023 - Above expectations and strong outlook
Redeye slightly raises estimates and fair value range following a strong Q4 from Stille where sales and EBIT exceeded our estimates.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/